BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 5083936)

  • 1. Turnover studies of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu.
    Strickland GT; Beckner WM; Leu ML; O'Reilly S
    Clin Sci; 1972 Nov; 43(5):605-15. PubMed ID: 5083936
    [No Abstract]   [Full Text] [Related]  

  • 2. Absorption of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu and 64 Cu.
    Strickland GT; Beckner WM; Leu ML
    Clin Sci; 1972 Nov; 43(5):617-25. PubMed ID: 5083937
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper.
    O'Reilly S; Weber PM; Oswald M; Shipley L
    Arch Neurol; 1971 Jul; 25(1):28-32. PubMed ID: 5146408
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
    O'Reilly S; Strickland GT; Weber PM; Beckner WM; Shipley L
    Arch Neurol; 1971 May; 24(5):385-90. PubMed ID: 5554862
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of genetic and acquired liver defects on radio-copper turnover in Wilson's disease.
    Osborn SB; Walshe JM
    Lancet; 1969 Jul; 2(7610):17-20. PubMed ID: 4182791
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kinetics of radioactive copper in Wilson's disease].
    Willvonseder R; Goldstein NP; Tauxe WN
    Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies with radioactive copper ( 64 Cu and 67 Cu); the incorporation of radioactive copper into caeruloplasmin in Wilson's disease and in primary biliary cirrhosis.
    Gibbs K; Walshe JM
    Clin Sci; 1971 Sep; 41(3):189-202. PubMed ID: 5571499
    [No Abstract]   [Full Text] [Related]  

  • 9. Body retention of injected 67Cu in patients with homozygous or heterozygous Wilson's disease and in normal subjects. Comparison of whole-body counting systems.
    Tauxe WN; Willvonseder R; Goldstein NP
    Mayo Clin Proc; 1974 Jun; 49(6):382-6. PubMed ID: 4209105
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormalities of the physiology of copper in Wilson's disease. II. The internal kinetics of copper.
    O'Reilly S; Pollycove M; Tono M; Herradora L
    Arch Neurol; 1971 Jun; 24(6):481-8. PubMed ID: 5089893
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pigment cirrhosis of the liver. I. Wilson's disease--hepatolenticular degeneration].
    Koziolowa H; Dziezbicka E
    Pol Arch Med Wewn; 1975 Nov; 54(5):491-5. PubMed ID: 1197060
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening asymptomatic family members for Wilson's disease.
    Lindahl JA; Sharp HL
    Minn Med; 1982 Aug; 65(8):473-5. PubMed ID: 6752690
    [No Abstract]   [Full Text] [Related]  

  • 13. The liver-thigh 64Cu ratio in Wilson's disease.
    Levi AJ; Williams HS
    Clin Sci; 1968 Apr; 34(2):379-83. PubMed ID: 5690128
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
    Willvonseder R; Goldstein NP; Tauxe WN
    Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal abnormalities in heterozygotes for Wilson's disease: genes or copper?
    Strickland GT; Leu ML
    Am J Med Sci; 1972 Aug; 264(2):157-60. PubMed ID: 4653120
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis of Wilson's disease in children with liver disease. A report of two families.
    Danks DM; Stevens BJ
    Lancet; 1969 Jan; 1(7584):22-5. PubMed ID: 4178768
    [No Abstract]   [Full Text] [Related]  

  • 17. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 18. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proceedings: Differentiation of homozygote and heterozygote, therapy and follow-up study in 4 families with Wilson's disease].
    Abendschein Th; Przuntek H; Wesch H; Gäng V
    MMW Munch Med Wochenschr; 1975 May; 117(20):842. PubMed ID: 805973
    [No Abstract]   [Full Text] [Related]  

  • 20. Copper kinetics in liver disease.
    Smallwood RA; McIlveen B; Rosenoer VM; Sherlock S
    Gut; 1971 Feb; 12(2):139-44. PubMed ID: 5548560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.